BioSpace News Archive

IntSights Cyber Intelligence, the leading provider of surface, deep and dark web cyber threat intelligence and digital risk protection solutions, announced today the release of the company’s latest research report, Chronic [Cyber] Pain: Exposed & Misconfigured Databases in the Healthcare industry.

Chubb has introduced its new Gap Supplement Medical plan – an enhanced supplemental healthcare insurance product designed to reimburse consumers for qualifying out-of-pocket expenses not reimbursed by their medical insurance plans

Dendreon Pharmaceuticals LLC, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today announced it has signed a long-term lease agreement for its current South Lake Union location

Berger Montague is pleased to announce that Covidien LP (“Defendant”) agreed to pay $13 million to resolve a False Claims Act lawsuit filed by Shareholder Shauna Itri on behalf of her client in November 2015.

The Alternative Energies and Atomic Energy Commision, Europe’s most innovative research center today announces it will host booth #50653 at CEA Tech Village, during CES 2019

Monmouth Junction, NJ, Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level.

OncoNano Medicine, Inc. today announced the completion of its Phase 1a clinical trial and expansion into Phase 1b to evaluate ONM-100, the intravenously administered imaging agent to detect tumors and metastatic lymph nodes in solid cancers during surgery.

QxMD Software Inc., a digital learning technology company that helps healthcare professionals (HCPs) to advance clinical practice with evidence-based research and decision support tools, today announced that the company had achieved a new membership milestone by exceeding the 200 million mark for annual aggregate views across the company’s HCP content engagement platform QxMD Pathways.

Chemotherapy causes chemotherapy-induced peripheral neuropathy (CIPN) in a significant number of patients, yet the pharmaceutical landscape is completely devoid of treatments to prevent CIPN.

Columbia research reveals importance of memory in driving key social behavior; offers insight into psychiatric disorders such as schizophrenia